Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis. [electronic resource]
Producer: 20131205Description: 196-9 p. digitalISSN:- 1613-7671
- Aged
- Aged, 80 and over
- Anemia -- chemically induced
- Austria
- Dose-Response Relationship, Drug
- Female
- Humans
- Immunologic Factors
- Lenalidomide
- Leukopenia -- chemically induced
- Male
- Middle Aged
- Primary Myelofibrosis -- complications
- Thalidomide -- administration & dosage
- Thrombocytopenia -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.